WASHINGTON (dpa-AFX) - Chemical company DuPont de Nemours, Inc. or DuPont
(DD) announced Tuesday it has signed an agreement to acquire Donatelle Plastics
Inc., a medical device contract manufacturer specializing in the design,
development and manufacture of medical components and devices.

The transaction is expected to close in the third quarter 2024, subject to
satisfaction of customary closing conditions and receipt of regulatory
approvals.

DuPont's healthcare exposure within the Industrial Solutions line of business of
the E&I segment includes Spectrum, a leader in medical device components, and
Liveo, a leader in silicone solutions for healthcare applications.

The acquisition of Donatelle Plastics will bring complementary advanced
technologies and capabilities including medical device injection molding, liquid
silicone rubber processing, precision machining, device assembly, and tool
building.

Donatelle Plastics has a strong financial growth profile aligned to attractive
therapeutic areas including electrophysiology, drug delivery, diagnostics,
cardiac rhythm management, neurostimulation, and orthopedic extremities.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX